Pediatrix Medical EBITDA Margin 2012-2025 | MD
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Pediatrix Medical (MD) over the last 10 years. The current EBITDA margin for Pediatrix Medical as of September 30, 2025 is .
| Pediatrix Medical EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2025-09-30 | $1.92B | $0.22B | 11.60% |
| 2025-06-30 | $1.94B | $0.19B | 9.74% |
| 2025-03-31 | $1.98B | $-0.03B | -1.27% |
| 2024-12-31 | $2.01B | $-0.04B | -1.84% |
| 2024-09-30 | $2.01B | $-0.19B | -9.22% |
| 2024-06-30 | $2.00B | $-0.18B | -8.74% |
| 2024-03-31 | $2.00B | $0.03B | 1.60% |
| 2023-12-31 | $2.00B | $0.05B | 2.26% |
| 2023-09-30 | $2.01B | $0.19B | 9.59% |
| 2023-06-30 | $2.00B | $0.20B | 10.02% |
| 2023-03-31 | $1.98B | $0.20B | 10.15% |
| 2022-12-31 | $1.97B | $0.21B | 10.65% |
| 2022-09-30 | $1.96B | $0.24B | 12.31% |
| 2022-06-30 | $1.96B | $0.25B | 12.91% |
| 2022-03-31 | $1.95B | $0.25B | 12.99% |
| 2021-12-31 | $1.91B | $0.24B | 12.55% |
| 2021-09-30 | $1.83B | $0.21B | 11.26% |
| 2021-06-30 | $1.80B | $0.17B | 9.23% |
| 2021-03-31 | $1.74B | $0.15B | 8.62% |
| 2020-12-31 | $1.73B | $0.13B | 7.73% |
| 2020-09-30 | $1.78B | $0.14B | 7.88% |
| 2020-06-30 | $1.77B | $0.15B | 8.59% |
| 2020-03-31 | $1.92B | $0.18B | 9.24% |
| 2019-12-31 | $2.33B | $0.26B | 11.09% |
| 2019-09-30 | $1.02B | $0.09B | 9.18% |
| 2019-06-30 | $1.42B | $0.18B | 12.76% |
| 2019-03-31 | $1.72B | $0.26B | 14.92% |
| 2018-12-31 | $1.72B | $0.28B | 16.13% |
| 2018-09-30 | $3.27B | $0.50B | 15.18% |
| 2018-06-30 | $3.29B | $0.52B | 15.85% |
| 2018-03-31 | $3.27B | $0.53B | 16.11% |
| 2017-12-31 | $3.25B | $0.54B | 16.56% |
| 2017-09-30 | $3.38B | $0.60B | 17.88% |
| 2017-06-30 | $3.34B | $0.63B | 18.96% |
| 2017-03-31 | $3.27B | $0.65B | 19.99% |
| 2016-12-31 | $3.18B | $0.67B | 20.89% |
| 2016-09-30 | $3.10B | $0.67B | 21.49% |
| 2016-06-30 | $2.99B | $0.65B | 21.81% |
| 2016-03-31 | $2.89B | $0.64B | 22.11% |
| 2015-12-31 | $2.78B | $0.62B | 22.45% |
| 2015-09-30 | $2.69B | $0.61B | 22.72% |
| 2015-06-30 | $2.59B | $0.59B | 22.78% |
| 2015-03-31 | $2.51B | $0.57B | 22.84% |
| 2014-12-31 | $2.44B | $0.56B | 22.91% |
| 2014-09-30 | $2.36B | $0.54B | 22.79% |
| 2014-06-30 | $2.28B | $0.52B | 22.85% |
| 2014-03-31 | $2.22B | $0.51B | 22.78% |
| 2013-12-31 | $2.15B | $0.49B | 22.84% |
| 2013-09-30 | $2.06B | $0.47B | 22.79% |
| 2013-06-30 | $1.98B | $0.45B | 22.77% |
| 2013-03-31 | $1.90B | $0.43B | 22.88% |
| 2012-12-31 | $1.82B | $0.42B | 23.12% |
| 2012-09-30 | $1.75B | $0.41B | 23.30% |
| 2012-06-30 | $1.69B | $0.39B | 23.37% |
| 2012-03-31 | $1.63B | $0.39B | 23.70% |
| 2011-12-31 | $1.59B | $0.38B | 23.99% |
| 2011-09-30 | $1.55B | $0.37B | 24.11% |
| 2011-06-30 | $1.49B | $0.36B | 24.16% |
| 2011-03-31 | $1.45B | $0.35B | 24.07% |
| 2010-12-31 | $1.40B | $0.34B | 23.91% |
| 2010-09-30 | $1.37B | $0.33B | 23.94% |
| 2010-06-30 | $1.35B | $0.32B | 23.85% |
| 2010-03-31 | $1.32B | $0.31B | 23.77% |
| 2009-12-31 | $1.29B | $0.31B | 23.76% |
| 2009-09-30 | $1.25B | $0.29B | 23.22% |
| 2009-06-30 | $1.19B | $0.27B | 23.04% |
| 2009-03-31 | $1.13B | $0.26B | 23.07% |
| 2008-12-31 | $1.07B | $0.25B | 23.76% |
| 2008-09-30 | $1.02B | $0.25B | 24.68% |
| 2008-06-30 | $0.99B | $0.25B | 25.43% |
| 2008-03-31 | $0.95B | $0.25B | 25.84% |
| 2007-12-31 | $0.92B | $0.23B | 25.19% |
| 2007-09-30 | $0.86B | $0.21B | 24.65% |
| 2007-06-30 | $0.85B | $0.21B | 24.56% |
| 2007-03-31 | $0.83B | $0.20B | 24.64% |
| 2006-12-31 | $0.81B | $0.20B | 25.34% |
| 2006-09-30 | $0.77B | $0.18B | 23.67% |
| 2006-06-30 | $0.74B | $0.17B | 23.27% |
| 2006-03-31 | $0.71B | $0.16B | 22.84% |
| 2005-12-31 | $0.68B | $0.15B | 22.47% |
| 2005-09-30 | $0.68B | $0.17B | 24.37% |
| 2005-06-30 | $0.66B | $0.16B | 24.66% |
| 2005-03-31 | $0.64B | $0.16B | 25.04% |
| 2004-12-31 | $0.62B | $0.16B | 26.33% |
| 2004-09-30 | $0.60B | $0.16B | 27.15% |
| 2004-06-30 | $0.59B | $0.16B | 27.20% |
| 2004-03-31 | $0.57B | $0.15B | 26.48% |
| 2003-12-31 | $0.55B | $0.15B | 26.27% |
| 2003-09-30 | $0.53B | $0.14B | 25.90% |
| 2003-06-30 | $0.50B | $0.13B | 25.50% |
| 2003-03-31 | $0.48B | $0.12B | 25.41% |
| 2002-12-31 | $0.47B | $0.12B | 25.38% |
| 2002-09-30 | $0.45B | $0.11B | 24.83% |
| 2002-06-30 | $0.43B | $0.11B | 24.36% |
| 2002-03-31 | $0.40B | $0.09B | 23.62% |
| 2001-12-31 | $0.36B | $0.08B | 22.82% |
| 2001-09-30 | $0.31B | $0.07B | 21.34% |
| 2001-06-30 | $0.28B | $0.05B | 19.27% |
| 2001-03-31 | $0.25B | $0.04B | 15.79% |
| 2000-12-31 | $0.24B | $0.04B | 15.70% |
| 2000-09-30 | $0.24B | $0.04B | 16.46% |
| 2000-06-30 | $0.23B | $0.04B | 17.32% |
| 2000-03-31 | $0.23B | $0.05B | 22.32% |
| 1999-12-31 | $0.23B | $0.06B | 25.00% |
| 1999-09-30 | $0.22B | $0.06B | 27.15% |
| 1999-06-30 | $0.21B | $0.06B | 29.25% |
| 1999-03-31 | $0.20B | $0.06B | 29.85% |
| 1998-12-31 | $0.19B | $0.06B | 30.81% |
| 1998-09-30 | $0.17B | $0.05B | 31.18% |
| 1998-06-30 | $0.16B | $0.05B | 30.97% |
| 1998-03-31 | $0.14B | $0.04B | 30.00% |
| 1997-12-31 | $0.13B | $0.04B | 28.68% |
| 1997-09-30 | $0.12B | $0.03B | 27.59% |
| 1997-06-30 | $0.10B | $0.03B | 26.92% |
| 1997-03-31 | $0.09B | $0.03B | 27.47% |
| 1996-12-31 | $0.08B | $0.02B | 27.50% |
| 1996-09-30 | $0.07B | $0.03B | 40.58% |
| 1996-06-30 | $0.06B | $0.03B | 57.63% |
| 1996-03-31 | $0.05B | $0.04B | 76.00% |
| 1995-12-31 | $0.04B | $0.04B | 100.00% |
| 1995-09-30 | $0.04B | $0.04B | 100.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $1.877B | $2.013B |
| Pediatrix Medical Group Inc. is a national medical group comprised of physician services practicing under the Pediatrix(R) brand. It provides services to women, babies and children across the continuum of care, both in hospital settings and office-based practices. Pediatrix Medical Group Inc., formerly known as Mednax Inc., is based in FORT LAUDERDALE, Fla. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $166.692B | 30.61 |
| HCA Healthcare (HCA) | United States | $107.089B | 17.73 |
| CVS Health (CVS) | United States | $99.777B | 11.47 |
| Elevance Health (ELV) | United States | $83.311B | 12.22 |
| Cencora (COR) | United States | $68.838B | 22.19 |
| Natera (NTRA) | United States | $31.987B | 0.00 |
| DiDi Global (DIDIY) | China | $23.485B | 21.70 |
| Labcorp Holdings (LH) | United States | $22.455B | 17.12 |
| Medpace Holdings (MEDP) | United States | $17.208B | 42.72 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $16.445B | 0.00 |
| Viatris (VTRS) | United States | $14.812B | 5.52 |
| BioMerieux (BMXMF) | France | $14.802B | 0.00 |
| ICON (ICLR) | Ireland | $14.747B | 14.63 |
| Solventum (SOLV) | United States | $13.786B | 13.38 |
| Revvity (RVTY) | United States | $12.755B | 23.49 |
| CochLear (CHEOY) | Australia | $11.760B | 0.00 |
| Charles River Laboratories (CRL) | United States | $10.813B | 20.82 |
| Avantor (AVTR) | United States | $8.291B | 12.67 |
| Sonic Healthcare (SKHHY) | Australia | $7.752B | 0.00 |
| Caris Life Sciences,�Inc (CAI) | United States | $7.556B | 0.00 |
| HealthEquity (HQY) | United States | $7.294B | 27.27 |
| BrightSpring Health Services (BTSG) | United States | $7.070B | 42.15 |
| Bausch + Lomb (BLCO) | Canada | $6.078B | 39.91 |
| PACS (PACS) | United States | $6.072B | 36.92 |
| Sotera Health (SHC) | United States | $5.449B | 26.27 |
| Alignment Healthcare (ALHC) | United States | $4.502B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $3.719B | 21.70 |
| GeneDx Holdings (WGS) | United States | $3.124B | 54.86 |
| Concentras Parent (CON) | United States | $2.762B | 17.24 |
| Organon (OGN) | United States | $2.277B | 2.40 |
| Progyny (PGNY) | United States | $2.114B | 41.56 |
| Surgery Partners (SGRY) | United States | $2.057B | 26.50 |
| Establishment Labs Holdings (ESTA) | United States | $1.962B | 0.00 |
| Ardent Health (ARDT) | United States | $1.231B | 4.02 |
| Teladoc Health (TDOC) | United States | $1.115B | 0.00 |
| Nutex Health (NUTX) | United States | $1.080B | 8.26 |
| CareDx (CDNA) | United States | $1.029B | 16.82 |
| Omada Health (OMDA) | United States | $0.933B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $0.910B | 14.89 |
| InnovAge Holding (INNV) | United States | $0.794B | 0.00 |
| Embecta (EMBC) | United States | $0.734B | 4.17 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.706B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.594B | 0.00 |
| CryoPort (CYRX) | United States | $0.552B | 0.00 |
| Enhabit (EHAB) | United States | $0.532B | 23.91 |
| Strata Critical Medical (SRTA) | United States | $0.515B | 0.00 |
| Charming Medical (MCTA) | Hong Kong, SAR China | $0.497B | 0.00 |
| SBC Medicals (SBC) | United States | $0.445B | 8.19 |
| Agilon Health (AGL) | United States | $0.423B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.343B | 5.51 |
| Oncology Institute (TOI) | United States | $0.330B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.288B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.279B | 58.75 |
| So-Young (SY) | China | $0.269B | 0.00 |
| KindlyMD (NAKA) | United States | $0.201B | 0.00 |
| Beauty Health (SKIN) | United States | $0.191B | 0.00 |
| LifeMD (LFMD) | United States | $0.181B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.141B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.139B | 0.00 |
| DocGo (DCGO) | United States | $0.081B | 0.00 |
| Biodesix (BDSX) | United States | $0.063B | 0.00 |
| Park Dental Partners (PARK) | United States | $0.062B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.047B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.046B | 0.00 |
| Pomdoctor - (POM) | China | $0.030B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.020B | 6.21 |
| OSR Holdings (OSRH) | United States | $0.019B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.018B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.016B | 0.00 |
| Lifeward (LFWD) | United States | $0.013B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.009B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.009B | 0.00 | |
| Pheton Holdings (PTHL) | China | $0.006B | 0.00 |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| Aclarion (ACON) | United States | $0.003B | 0.00 |
| XWELL (XWEL) | United States | $0.002B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.000B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |